Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin

Details for Australian Patent Application No. 2005299808 (hide)

Owner Novartis AG

Inventors Hughes, Thomas Edward; Burkey, Bryan

Agent Davies Collison Cave

Pub. Number AU-B-2005299808

PCT Pub. Number WO2006/047248

Priority 60/621,891 25.10.04 US

Filing date 21 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 20 August 2009

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/047248 Priority application(s): WO2006/047248

20 August 2009 Application Accepted

  Published as AU-B-2005299808

17 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299809-Anti-IL-22RA antibodies and binding partners and methods of using in inflammation

2005299806-Regulated gas supply system